Recent Progress in Lipid Nanoparticles for Cancer Theranostics: Opportunity and Challenges

Abstract

Cancer is one of the major leading causes of mortality in the world. The implication of nanotherapeutics in cancer has garnered splendid attention owing to their capability to efficiently address various difficulties associated with conventional drug delivery systems such as non-specific biodistribution, poor efficacy, and the possibility of occurrence of multi-drug resistance. Amongst a plethora of nanocarriers for drugs, this review emphasized lipidic nanocarrier systems for delivering anticancer therapeutics because of their biocompatibility, safety, high drug loading and capability to simultaneously carrying imaging agent and ligands as well. Furthermore, to date, the lack of interaction between diagnosis and treatment has hampered the efforts of the nanotherapeutic approach alone to deal with cancer effectively. Therefore, a novel paradigm with concomitant imaging (with contrasting agents), targeting (with biomarkers), and anticancer agent being delivered in one lipidic nanocarrier system (as cancer theranostics) seems to be very promising in overcoming various hurdles in effective cancer treatment. The major obstacles that are supposed to be addressed by employing lipidic theranostic nanomedicine include nanomedicine reach to tumor cells, drug internalization in cancer cells for therapeutic intervention, off-site drug distribution, and uptake via the host immune system. A comprehensive account of recent research updates in the field of lipidic nanocarrier loaded with therapeutic and diagnostic agents is covered in the present article. Nevertheless, there are notable hurdles in the clinical translation of the lipidic theranostic nanomedicines, which are also highlighted in the present review along with plausible countermeasures.

Nanotechnology-Based Diagnostic and Therapeutic Strategies for Neuroblastoma

“…Although, the application of NPs has effectively overcome the shortcomings of conventional oncology diagnosis and therapy, nanomaterial-based cancer treatment still faces many challenges. For example, when contrast agents in lipid therapeutic nanomedicines interact with biological materials due to their incompatibility or potential toxicity, adverse reactions such as inflammation, immune response or related diseases in the organism will occur ( Dilnawaz et al, 2018 ; Bukhari et al, 2021 ). Superparamagnetic Fe3O4 NPs were once considered to be relatively inert carriers for therapeutic and diagnostic drugs.…”

Nanomaterials as Promising Theranostic Tools in Nanomedicine and Their Applications in Clinical Disease Diagnosis and Treatment

“…The implication of liposomes in tumor has garnered significant attention owing to their biocompatibility, safety and high drug loading [68]. Liposomes are composed of phospholipids and cholesterol and other stable components.…”

Lipid Nanoparticles Based Cosmetics with Potential Application in Alleviating Skin Disorders

“…Nanoemulsions which are colloidal dispersion of nanoscale droplets of one fluid within another fluid are being widely used in skincare products, deodorants, sunscreens and hair care products. Their notable characteristic feature of rapid penetration, assimilating textures and hydration capability allows their inclusive utility in skin delivery of cosmetics [16][17][18].…”